Literature DB >> 3340312

[Adrenal metastasis: clinical and pathological aspects].

C Belleggia1, A Piga, U Torresi, R Montironi, R Cellerino.   

Abstract

The clinical and autopsy records of 91 patients who died of various malignancies in January 1980-December 1985 were reviewed with regards to metastatic involvement of the adrenal glands. Metastatic involvement was found in 28/91 i.e. 30.7% of all cases, and in 17/30 cases of lung cancer (56.6%). Although in the majority of cases adrenal metastases were associated with widespread metastatic (terminal) disease, thus questioning the utility of clinical surveillance, in 4/17 cases with lung cancer the adrenals were the only visceral site of metastasis. Symptoms were rarely seen and were in all instances aspecific and attributable to the underlying cancer. Early and accurate identification of suprarenal metastasis would, at least in these cases, be a great help in deciding on the therapeutic approach. Unfortunately our ability to diagnose these metastases is somewhat limited partly because the symptoms are few and aspecific, partly because we lack efficient and economical diagnostic techniques. In fact the simpler laboratory techniques cannot identify early metastatic lesions. However assessment of the adrenals should be part of routine staging and restaging procedures in some neoplasias, for the frequency and clinical relevance of these lesions.

Entities:  

Mesh:

Year:  1988        PMID: 3340312

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  2 in total

1.  An unusual case of adrenal failure due to isolated metastases of breast cancer.

Authors:  M V Davì; G Francia; P Brazzarola; M Olivieri; A Petrozziello; A Orsolini; R Petronio; P L Sussi
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

2.  A Retrospective Review of CyberKnife Stereotactic Body Radiotherapy for Adrenal Tumors (Primary and Metastatic): Winthrop University Hospital Experience.

Authors:  Amishi Desai; Hema Rai; Jonathan Haas; Matthew Witten; Seth Blacksburg; Jeffrey G Schneider
Journal:  Front Oncol       Date:  2015-08-17       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.